Recursion Software Revenue and Competitors
Estimated Revenue & Valuation
- Recursion Software's estimated annual revenue is currently $870k per year.
- Recursion Software's estimated revenue per employee is $87,000
Employee Data
- Recursion Software has 10 Employees.
Recursion Software's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Business Development | Reveal Email/Phone |
2 | VP/Controller | Reveal Email/Phone |
3 | Sr Software Engineer | Reveal Email/Phone |
Recursion Software Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $17.5M | 121 | 12% | N/A | N/A |
#2 | $90.4M | 499 | 24% | N/A | N/A |
#3 | $2M | 20 | -23% | N/A | N/A |
#4 | $226.8M | 1094 | 46% | $261M | N/A |
#5 | $406.7M | 2600 | 8% | $26.1M | N/A |
#6 | $14.8M | 102 | -61% | N/A | N/A |
#7 | $8.6M | 66 | -1% | N/A | N/A |
#8 | $13.2M | 91 | -5% | $752.5M | N/A |
#9 | $36.5M | 229 | 6% | N/A | N/A |
#10 | $56.6M | 312 | 23% | N/A | N/A |
What Is Recursion Software?
N/A
Total Funding
10
Number of Employees
$870k
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Recursion Software News
2022-04-20 - AI in Healthcare Market to See Huge Growth by 2030 | NVIDIA ...
... Enlitic, Next IT, Welltok, ICarbonX, Recursion Pharmaceuticals, ... in Healthcare market segments by Types: Hardware, Software, Services.
2022-03-22 - The great puzzle of the body and disease is beginning to yield to AI, says
Recursion CEO
Recursion has roughly 50 programs in process to either find novel cures or repurpose existing ones, many of them for so-called orphan conditions...
2022-03-22 - NVIDIA Hopper GPU Architecture Accelerates Dynamic ...
Recursion involves breaking a problem down into simpler sub-problems ... Paired with the NVIDIA cuOpt AI logistics software, this speedup in...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 10 | 0% | N/A |
#2 | $0.9M | 10 | 0% | N/A |
#3 | $1.5M | 10 | -66% | N/A |
#4 | $0.9M | 10 | N/A | N/A |
#5 | $0.9M | 10 | -9% | N/A |